Life Sciences Corporate Partnering & Licensing
#1 Globally for Pharma and Biotech Licensing Deals
Cidara Enters Collaboration With Janssen
Learn More
Hansa Biopharma Announces Collaboration with Sarepta
Learn More
Neurocrine Partners With Takeda to Address Psychiatric Disorders
Learn More
Arcus Biosciences Announces 10-year Partnership with Gilead
Learn More
Fate Therapeutics Licensing and Platform Collaboration with Janssen Biotech
Learn More
Sangamo Announces Global Licensing Collaboration Agreement with Biogen
Learn More
Harpoon Therapeutics Announces Worldwide Collaboration with AbbVie
Learn More
Adaptive Biotechnologies Announces Strategic Collaboration with Genentech
Learn More
Goldfinch Bio Announces Strategic Collaboration with Gilead
Learn More
Why Cooley
- 40+ professionals across the US, UK and Asia exclusively focused on corporate partnering, licensing, M&A and other commercial transactions specific to life sciences companies
- Involvement with hundreds of transactions across various technologies and stages of product development
- Team includes prior pharmaceutical marketing specialists, business consultants, biotech researchers and in-house counsel at life sciences companies including Amgen, Exelixis, Jazz Pharma, and ZymoGenetics
- 50% of the attorneys in our corporate partnering group have earned a bachelor’s degree with a life sciences focus, 35% a Master’s degree and 21% a PhD
- Well-versed in the business, regulatory and commercial issues inherent in transactions, with the ability to call on a team of intellectual property, regulatory, reimbursement, tax, antitrust and other specialists as needed
- Essentially, we serve as outsourced business/corporate development for many of our clients
- Actively represent almost 1,800 public and private life science company clients worldwide
30+
attorneys around the globe fully dedicated to life sciences corporate partnering & licensing deals
Life sciences partnering 2020 recap
Members of our life sciences partnering team look back on their 2020 highlights, from advising companies working diligently to battle COVID-19 and other diseases to collaborating with clients and colleagues in new ways and more.
Watch video
Recognition
- Legal 500 US: Tier 1 for Healthcare: Life Sciences in 2021
- LMG Life Sciences: "Highly Recommended” law firm for general corporate, licensing & collaborations, and M&A in 2019
- BioPharm Insight: #1 in Biotechnology and Pharmaceutical Licensing League Table Report
- Allicense Deal of the Year: 15 Cooley transactions awarded or nominated since 2000
- Chambers USA: Band 1 for Life Sciences
- The Best Lawyers in America: 2019 Biotechnology Law Firm of the Year
According to industry peers, the licensing, tax and inversion, private investment, capital market and M&A work performed by Cooley is top tier.
– LMG Life Sciences
ViewHide related contacts
+-
Listing Returned 0 Results.
-
{{ item.name }}
{{ item.title }}
{{ item.location }}{{ item.secondaryoffices}}
-
{{ item.name }}
{{ item.title }}
{{ item.location }}{{ item.secondaryoffices}}
ViewHide related news
+-
Listing Returned 0 Results.
ViewHide related events
+-
Listing Returned 0 Results.